There was no change in TP53 RNA levels and only a ~1.5-fold increase (p = 0.02) in PPARG RNA levels; however, expression of the protein products, their modification, and interactions might have changed in FSHD cells. The gene discussed is TP53; the disease is facioscapulohumeral muscular dystrophy.